Abstract
Objectives: The aim of this article was to review the current role of brain PET in the diagnosis of Alzheimer dementia. The characteristic patterns of glucose metabolism on brain FDG-PET can help in differentiating Alzheimer's disease from other causes of dementia such as frontotemporal dementia and dementia of Lewy body. Amyloid brain PET may exclude significant amyloid deposition and thus Alzheimer's disease in appropriate clinical setting. Conclusions: FDG-PET and amyloid PET imaging are valuable in the assessment of patients with Alzheimer's disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | e413-e426 |
| Journal | Clinical nuclear medicine |
| Volume | 39 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 1 2014 |
Keywords
- Alzheimer's disease
- Amyloid brain PET
- Dementia
- FDG brain PET
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging